← Back to Search

Stigma Counseling for HIV Prevention

N/A

Recruiting

Led By Lisa A Eaton, PhD

Research Sponsored by University of Connecticut

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 or older

Men (based on male sex assignment at birth)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial will study how stigma and substance use affect pre-exposure prophylaxis (PrEP) use for HIV prevention among black sexual minority men.

Who is the study for?

This trial is for Black men and transwomen over the age of 18, who use substances, have had condomless sex with a man in the past six months, and are HIV negative. Participants must identify as part of the African diaspora and will be tested for recent substance use.Check my eligibility

What is being tested?

The study is examining stigma counseling as an intervention to encourage pre-exposure prophylaxis (PrEP) usage among participants. It aims to understand how stigma and substance use affect PrEP adherence for HIV prevention in this demographic.See study design

What are the potential side effects?

While specific side effects are not listed for stigma counseling interventions, participants may experience emotional or psychological discomfort when discussing sensitive topics related to substance use, sexual practices, or experiences of stigma.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I was assigned male at birth.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

PrEP Use

Secondary outcome measures

PrEP stigma

Trial Design

1Treatment groups

Experimental Treatment

Group I: Stigma Counseling for PrEP AccessExperimental Treatment1 Intervention

Behavioral counseling

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of ConnecticutLead Sponsor

183 Previous Clinical Trials

157,673 Total Patients Enrolled

Lisa A Eaton, PhDPrincipal InvestigatorUniversity of Connecticut

1 Previous Clinical Trials

600 Total Patients Enrolled

Media Library

Stigma Counseling for PrEP Access Clinical Trial Eligibility Overview. Trial Name: NCT04832477 — N/A

HIV Research Study Groups: Stigma Counseling for PrEP Access

HIV Clinical Trial 2023: Stigma Counseling for PrEP Access Highlights & Side Effects. Trial Name: NCT04832477 — N/A

Stigma Counseling for PrEP Access 2023 Treatment Timeline for Medical Study. Trial Name: NCT04832477 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still open for this clinical experiment?

"The evidence from clinicaltrials.gov supports that this trial is still open for enrollment and recruitment of participants. The study was initially announced on September 30th 2021 and the latest updates were posted January 11th 2022."

Answered by AI

What is the total number of participants involved in this clinical experiment?

"Affirmative, according to clinicaltrials.gov the trial posted on September 30th 2021 is currently seeking individuals for participation. 500 subjects are needed from one medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Assessing the PrEP Care Cascade Among Black Men and Transwomen in the Southeastern US

Lisa Eaton 2021. "Assessing the PrEP Care Cascade Among Black Men and Transwomen in the Southeastern US". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04832477.

All > Substance Abuse > Hiv